Investing.com - DR Horton (NYSE: DHI) reported third quarter EPS of $3.90, $1.12 better than the analyst estimate of $2.78. Revenue for the quarter came in at $9.73B versus the consensus estimate of $8.2B.
Guidance
DR Horton sees FY 2023 EPS of versus the analyst consensus of $32.30.
DR Horton sees FY 2023 revenue of $34.70B-$35.10B
DR Horton's stock price closed at $127.85. It is up 19.96% in the last 3 months and up 68.60% in the last 12 months.
DR Horton saw 15 positive EPS revisions and 0 negative EPS revisions in the last 90 days. See DR Horton's stock price’s past reactions to earnings here.
According to InvestingPro, DR Horton's Financial Health score is "great performance".
Check out DR Horton's recent earnings performance, and DR Horton's financials here.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar